Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950127-02-000065
Filing Date
2002-01-29
Accepted
2002-01-29 00:00:00
Documents
10
Period of Report
2001-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A a839469_10ka.txt 10-K/A 147478
3 EXHIBIT 10.1A - GSK LICENSE AGREEMENT a837328_exh10point1a.txt EX-10 118811
4 EXHIBIT 10.1B - GSK AMENDMENT NO. 1 a837333_exh10point1b.txt EX-10 12002
5 EXHIBIT 10.1C - GSK AMENDMENT NO. 2 a769909_exh10point1c.txt EX-10 5363
6 EXHIBIT 10.2A - PMC CO-PROMOTION AGREEMENT a837331_exh10point2a.txt EX-10 81409
7 EXHIBIT 10.2B - APHTON SUPPLY AGREEMENT a837335_exh10point2b.txt EX-10 36541
8 EXHIBIT 10.2C - PMC SUPPLY AGREEMENT a837337_exh10point2c.txt EX-10 44190
9 EXHIBIT 10.2D - PMC LETTER AGREEMENT a837738_exh10point2d.txt EX-10 7882
10 EXHIBIT 23.1 a_exh23point1.txt EX-23 406
11 EXHIBIT 23.2 a_exh23point2.txt EX-23 542
  Complete submission text file 0000950127-02-000065.txt   457371
Mailing Address PO BOX 1049 STE 51-507 WOODLAND CA 95776
Business Address PO BOX 1049 STE 51-507 WOODLAND CA 95776 5306616077
APHTON CORP (Filer) CIK: 0000840319 (see all company filings)

EIN.: 953640931 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19122 | Film No.: 02519855
SIC: 2836 Biological Products, (No Diagnostic Substances)